Post-harvesting longevity of bird of paradise (Strelitzia spp.) treated with carnauba wax

  Strelitzias are tropical plants that have shown great interest in the market and can be used in landscaping in tropical floral arrangements. Aiming to extend its postharvest life, the objective of the work was to evaluate different concentrations of the commercial product based on carnauba wax in the postharvest longevity of Strelitzia juncea and Strelitzia reginae leaves. The experiment was conducted in a completely randomized design with five treatments and six repetitions, with one leaf per repetition for each species. The concentrations used were: 0% (control), 2%, 20%, 40% and 100%. The loss of leaf mass (%) and the visual quality of the leaves were evaluated through the criterion of notes, in addition to making use of anatomical analyzes of the stomatal structures of the leaves through scanning microscopy. The loss of mass was reduced with the increase of the wax concentration, however, high doses provided increased loss. The use of carnauba wax proved efficient at concentrations of 20 and 40%, maintaining the commercial quality of the leaves of S. reginae and S. juncea until the 24th day, while in the control treatment, the leaves maintained a commercial pattern until the 16th for S. reginae and 18th day for S. juncea. The deposition of wax in the stomatal structures may have influenced the loss of mass of both species as observed by scanning microscopy.As Strelitzias são plantas tropicais que têm despontado grande interesse do mercado, podendo ser utilizadas no paisagismo em arranjos florais tropicais. Visando ampliar sua vida pós-colheita, o objetivo do trabalho foi avaliar diferentes concentrações do produto comercial a base de cera de carnaúba na longevidade pós-colheita de folhas de Strelitzia juncea e Strelitzia reginae. O experimento foi conduzido em delineamento inteiramente casualizado com cinco tratamentos e seis repetições, com uma folha por repetição para cada espécie. As concentrações utilizadas foram: 0% (controle), 2%, 20%, 40% e 100%. Avaliaram-se a perda de massa foliar (%) e a qualidade visual das folhas por meio do critério de notas, além de se fazer uso de análises anatômicas das estruturas estomáticas das folhas através de microscopia de varredura. A perda de massa foi reduzida com o aumento da concentração de cera, no entanto, altas doses proporcionaram aumento da perda. O uso de cera de carnaúba se mostrou eficiente nas concentrações de 20 e 40%, mantendo a qualidade comercial das folhas de S. reginae e S. juncea até o 24º dia, enquanto no tratamento controle, as folhas mantiveram padrão comercial até o 16° para S. reginae e 18° dia para S. juncea. A deposição de cera nas estruturas estomáticas pode ter influenciado na perda de massa de ambas as espécies conforme foi observado por meio da microscopia de varredura

In vitro control of phytopathogenic fungi and damping-off of tomato by Bacillus velezensis LABIM40 (CMRP 4489)

The in vitro antagonistic activity of Bacillus velezensis LABIM40 (strain CMRP 4489) was assessed against Alternaria linariae, Botryotinia squamosa, Colletotrichum lindemuthianum, Gibberella zeae, and Rhizoctonia solani. An experiment was conducted using treated seeds under growth chamber conditions to determine the impact of various LABIM40 formulations on tomato seedling growth and the biocontrol of damping-off caused by R. solani. The treatments included the use of LABIM40 cell suspension, LABIM40 cell-free supernatant (CFS), 10 times concentrated CFS (10× CFS), commercial products based on Bacillus amyloliquefaciens (CP_1) and Bacillus subtilis (CP_2), and water. The effects of these products were assessed on tomato seedlings grown in sterile substrate or substrate inoculated with R. solani. In a dual culture test, B. velezensis LABIM40 inhibited the mycelial growth of the aforementioned fungal pathogens by 46.6%, 67.4%, 64.7%, 49.0%, and 54.4%, respectively. The minimum inhibitory concentration against each fungus was determined using varying concentrations of CFS in potato dextrose agar medium, followed by a regression analysis of mycelial growth inhibition. Except for A. linariae, the logarithmic model provided the best fit in all cases. Tomato seedlings from seeds treated with 10× CFS in inoculated substrate exhibited a survival rate 57% higher than that exhibited by the control treatment. However, no growth promotion was observed in tomato plants from seeds treated with LABIM40 cells or its CFS metabolites. In summary, these findings highlight the antagonistic activity of B. velezensis LABIM40 against A. linariae, B. squamosa, C. lindemuthianum, G. zeae, and R. solani, as demonstrated by dual culture and CFS diffusion tests. This suggests its potential as a biocontrol agent for damping-off in tomatoes

New Insights on Alternative Hosts of <i>Xanthomonas vasicola</i> pv. <i>vasculorum</i>, the Causal Agent of Bacterial Leaf Streak of Maize

Bacterial leaf streak (BLS) of maize (Zea mays), caused by the bacterium Xanthomonas vasicola pv. vasculorum (Xvv), was first reported in Brazil in 2018. In this study, we evaluated 52 species of cultivated plants, cover crops, forage, and grasses that are used in succession or crop rotation with maize, and weeds with natural occurrence in maize-producing regions, to determine their potentials as alternative hosts for Xvv. We investigated (i) the pathogenicity of Xvv based on symptom development, (ii) epiphytic colonization of the bacterium in asymptomatic plants, and (iii) bacterial colonization in plant tissues using scanning electron microscopy (SEM) in symptomatic and asymptomatic species. Ten species, all belonging to the Poaceae family, presented symptoms after Xvv infection, including Avena sativa (cvs. IPR Afrodite and IPR Esmeralda), A. strigosa (cv. IPR 161), Hordeum vulgare (cv. BRS Cauê), Oryza sativa (cv. IPR 117), Brachiaria brizantha (Brizantha and cv. Marandu), Digitaria horizontalis, D. insularis, Echinochloa colonum, Eleusine indica, and Sorghum arundinaceum. Furthermore, epiphytic colonization by Xvv was observed in 23 asymptomatic species. Scanning micrographs revealed that Xvv cells and their aggregates were distributed throughout the leaf surface. In addition, bacterial colonization in the intercellular tissues of the substomatal chambers of white oat, black oat, and maize was observed across the tissue fractures. Despite showing typical symptoms of Xvv infection, SEM examination revealed evidence of Xvv colonization only on the leaf surface of rice. In asymptomatic species, such as rye, sorghum, and millet, a low number of bacterial cells were found on the leaf surface. However, no evidence of internal tissue colonization was observed in millet fractures, suggesting that Xvv survives only epiphytically in this species

Synergistic and additive effect of oregano essential oil and biological silver nanoparticles against multidrug-resistant bacterial strains

Bacterial resistance to conventional antibiotics has become a clinical and public health problem, making therapeutic decisions more challenging. Plant compounds and nanodrugs have been proposed as potential antimicrobial alternatives. Studies have shown that oregano (Origanum vulgare) essential oil (OEO) and silver nanoparticles have potent antibacterial activity, also against multidrug-resistant strains; however, the strong organoleptic characteristics of OEO and the development of resistance to these metal nanoparticles can limit their use. This study evaluated the antibacterial effect of a two-drug combination of biologically synthesized silver nanoparticles (bio-AgNP), produced by Fusarium oxysporum, and OEO against Gram-positive and Gram-negative bacteria, including multidrug-resistant strains. OEO and bio-AgNP showed bactericidal effects against all seventeen strains tested, with minimal inhibitory concentrations (MIC) ranging from 0.298 to 1.193 mg/mL and 62.5 to 250 µM, respectively. Time-kill curves indicated that OEO acted rapidly (within 10 min), while the metallic nanoparticles took 4 h to kill Gram-negative bacteria and 24 h to kill Gram-positive bacteria. The combination of the two compounds resulted in a synergistic or additive effect, reducing their MIC values and reducing the time of action compared to bio-AgNP used alone, i.e., 20 min for Gram-negative bacteria and 7 h for Gram-positive bacteria. Scanning electron microscopy (SEM) revealed similar morphological alterations in Staphylococcus aureus (non-methicillin-resistant S. aureus, non-MRSA) cells exposed to three different treatments (OEO, bio-AgNP and combination of the two), which appeared cell surface blebbing. Individual and combined treatments showed reduction in cell density and decrease in exopolysaccharide matrix compared to untreated bacterial cells. It indicated that this composition have an antimicrobial activity against S. aureus by disrupting cells. Both compounds showed very low hemolytic activity, especially at MIC levels. This study describes for the first time the synergistic and additive interaction between OEO and bio-AgNP produced by F. oxysporum against multidrug-resistant bacteria, such as MRSA, and β-lactamase- and carbapenemase-producing Escherichia coli and Acinetobacter baumannii strains. These results indicated that this combination can be an alternative in the control of infections with few or no treatment options

Promising antifungal activity of new oxadiazole against Candida krusei.

Candida krusei is one of the most common agents of invasive candidiasis and candidemia worldwide, leading to high morbidity and mortality rates. This species has become a problem due to its intrinsic resistance and reduced susceptibility to azoles and polyenes. Moreover, the number of antifungal drugs available for candidiasis treatment is limited, demonstrating the urgent need for the discovery of novel alternative therapies. In this work, the in vivo and in vitro activities of a new oxadiazole (LMM11) were evaluated against C. krusei. The minimum inhibitory concentration ranged from 32 to 64 μg/mL with a significant reduction in the colony forming unit (CFU) count (~3 log10). LMM11 showed fungicidal effect, similar to amphotericin, reducing the viable cell number (>99.9%) in the time-kill curve. Yeast cells presented morphological alterations and inactive metabolism when treated with LMM11. This compound was also effective in decreasing C. krusei replication inside and outside macrophages. A synergistic effect between fluconazole and LMM11 was observed. In vivo treatment with the new oxadiazole led to a significant reduction in CFU (0.85 log10). Furthermore, histopathological analysis of the treated group exhibited a reduction in the inflammatory area. Taken together, these results indicate that LMM11 is a promising candidate for the development of a new antifungal agent for the treatment of infections caused by resistant Candida species such as C. krusei

Preclinical approaches in vulvovaginal candidiasis treatment with mucoadhesive thermoresponsive systems containing propolis.

Vulvovaginal candidiasis (VVC) is a common vaginitis that affects women, especially in childbearing age, caused by Candida albicans in almost 80% of cases. Considering the limited drug arsenal available and the increasing fungal resistance profile, the search for new therapeutic sources with low toxicity and easy administration should be supported. Propolis has been used as a traditional medicine for multiple diseases, considering its particular composition and pharmaceutical properties that permits its wide applicability; it has also emerged as a potential antifungal agent. Thus, this study performed an in vitro and in vivo investigation into the efficacy of a new mucoadhesive thermoresponsive platform for propolis delivery (MTS-PRPe) in a preclinical murine model of VVC treatment caused by C. albicans. The methodologies involved chemical analysis, an assessment of the rheological and mucoadhesive properties of propolis formulations, in vitro and in vivo antifungal evaluations, histological evaluations and electron microscopy of the vaginal mucosa. The results demonstrated the antifungal activity of propolis extract and MTS-PRP against the standard strain and a fluconazole-resistant clinical isolate of C. albicans, in both in vitro and in vivo assays. These results were similar and even better, depending on the propolis concentration, when compared to nystatin. Thus, the formulation containing propolis exhibited good performance against C. albicans in a vulvovaginal candidiasis experimental model, representing a promising opportunity for the treatment of this infection